Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

SHINECO - 9 Year Stock Price History | SISI

Historical daily share price chart and data for SHINECO since 2016 adjusted for splits and dividends. The latest closing stock price for SHINECO as of February 11, 2025 is 1.30.
  • The all-time high SHINECO stock closing price was 62380.58 on September 28, 2016.
  • The SHINECO 52-week high stock price is 117.55, which is 8942.3% above the current share price.
  • The SHINECO 52-week low stock price is 1.30, which is 0% below the current share price.
  • The average SHINECO stock price for the last 52 weeks is 18.89.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
SHINECO Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.6500 2.0750 2.0750 1.3000 1.3000 -71.30%
2024 22.3860 28.7280 108.2400 2.0400 4.5300 -83.24%
2023 107.9199 532.8000 532.8000 21.1680 27.0240 -95.27%
2022 455.3520 1327.2000 1327.2000 174.4800 571.1760 -64.16%
2021 1811.2571 724.8000 4459.1999 724.8000 1593.5999 117.35%
2020 945.2573 1350.0000 1576.8000 590.6880 733.2000 -45.89%
2019 1557.9690 1306.8000 3412.7999 944.5680 1354.9680 8.16%
2018 3050.5984 4881.5999 5507.9999 1144.8000 1252.8000 -74.78%
2017 7196.1095 8488.7998 11339.9998 3866.3999 4967.9999 -45.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.003B $0.010B
Shineco, Inc. is principally engaged in the production and distribution of herbal medicines, organic agricultural produce, specialized textiles and other health and well-being focused plant-based products primarily in China. Shineco, Inc. is headquartered in Beijing, China.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.557B 30.23
Chugai Pharmaceutical (CHGCY) Japan $73.258B 28.91
Takeda Pharmaceutical (TAK) Japan $43.305B 9.58
Sandoz Group AG (SDZNY) Switzerland $21.476B 0.00
Merck (MKKGY) Germany $19.083B 17.09
Astellas Pharma (ALPMY) Japan $16.957B 12.01
United Therapeutics (UTHR) United States $15.793B 15.54
Summit Therapeutics (SMMT) United States $15.243B 0.00
Neurocrine Biosciences (NBIX) United States $15.239B 45.75
Shionogi (SGIOY) Japan $12.318B 12.34
Orion OYJ (ORINY) Finland $7.466B 20.99
Madrigal Pharmaceuticals (MDGL) United States $7.203B 0.00
Corcept Therapeutics (CORT) United States $7.129B 54.00
Stevanato Group S.p.A (STVN) Italy $6.808B 44.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.152B 0.00
Grifols, S.A (GRFS) Spain $4.806B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.779B 9.78
Crinetics Pharmaceuticals (CRNX) United States $3.590B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.750B 12.47
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
Centessa Pharmaceuticals (CNTA) United Kingdom $2.352B 0.00
Soleno Therapeutics (SLNO) United States $2.198B 0.00
Hypermarcas (HYPMY) Brazil $2.068B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.949B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.808B 0.00
Dyne Therapeutics (DYN) United States $1.706B 0.00
Evotec AG (EVO) Germany $1.666B 0.00
Indivior (INDV) United States $1.468B 5.98
Guardian Pharmacy Services (GRDN) United States $1.408B 0.00
Ardelyx (ARDX) United States $1.343B 0.00
ARS Pharmaceuticals (SPRY) United States $1.244B 0.00
Xencor (XNCR) United States $1.207B 0.00
Ocular Therapeutix (OCUL) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.158B 0.00
Harrow (HROW) United States $1.105B 0.00
Enliven Therapeutics (ELVN) United States $1.098B 0.00
Collegium Pharmaceutical (COLL) United States $0.998B 5.45
Bioventus (BVS) United States $0.880B 27.80
Cronos Group (CRON) Canada $0.773B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.771B 0.00
Relay Therapeutics (RLAY) United States $0.755B 0.00
Verve Therapeutics (VERV) United States $0.708B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.03
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Xeris Biopharma Holdings (XERS) United States $0.540B 0.00
OmniAb (OABI) United States $0.524B 0.00
Altimmune (ALT) United States $0.491B 0.00
Savara (SVRA) United States $0.487B 0.00
ProKidney (PROK) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Akebia Therapeutics (AKBA) United States $0.471B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Oruka Therapeutics (ORKA) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.446B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 174.21
Zevra Therapeutics (ZVRA) United States $0.421B 0.00
Siga Technologies (SIGA) United States $0.413B 4.82
Tourmaline Bio (TRML) United States $0.384B 0.00
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Aldeyra Therapeutics (ALDX) United States $0.357B 0.00
Korro Bio (KRRO) United States $0.339B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
4D Molecular Therapeutics (FDMT) United States $0.301B 0.00
CytoDyn (CYDY) United States $0.277B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
Heron Therapeutics (HRTX) United States $0.272B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 16.10
Amylyx Pharmaceuticals (AMLX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Larimar Therapeutics (LRMR) United States $0.229B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Acrivon Therapeutics (ACRV) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Lexeo Therapeutics (LXEO) United States $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Lyell Immunopharma (LYEL) United States $0.173B 0.00
Silence Therapeutics (SLN) United Kingdom $0.172B 0.00
Inhibikase Therapeutics (IKT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Nanobiotix S.A (NBTX) France $0.166B 0.00
Champions Oncology (CSBR) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Telomir Pharmaceuticals (TELO) United States $0.135B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
ElectroCore (ECOR) United States $0.106B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Protara Therapeutics (TARA) United States $0.100B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Pyxis Oncology (PYXS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.20
ESSA Pharma (EPIX) Canada $0.075B 0.00
Mural Oncology (MURA) Ireland $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Century Therapeutics (IPSC) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Incannex Healthcare (IXHL) Australia $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
BioVie (BIVI) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Traws Pharma (TRAW) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Dominari Holdings (DOMH) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00